Literature DB >> 8386825

The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.

F Galland1, A Karamysheva, M J Pebusque, J P Borg, R Rottapel, P Dubreuil, O Rosnet, D Birnbaum.   

Abstract

Three receptor tyrosine kinases, FLT1, FLK1 and FLT4, contain seven immunoglobin-like domains in their extracellular region and are strongly related by sequence similarities to each other and, to a lesser degree, to the class III receptors CSF1R/FMS, PDGFR, SLFR/KIT and FLT3/FLK2. They constitute a family of receptors putatively involved in the growth regulation of endothelial cells. We describe here the structure and pattern of expression of the human FLT4 gene. Two FLT4 transcripts of 5.8 and 4.5 kb are expressed in the human placenta and several hematopoietic cell lines. In mouse, a 5.8-kb transcript is expressed in a variety of tissues. A translational product 1298 amino acids in length is predicted to be encoded by the largest open reading frame. The FLT4 protein, when transiently expressed in Cos-7 cells and immunoprecipitated with a FLT4-specific rabbit immune serum, has an apparent molecular weight of 170 kDa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386825

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  Possible genetic predisposition to lymphedema after breast cancer.

Authors:  Beth Newman; Felicity Lose; Mary-Anne Kedda; Mathias Francois; Kaltin Ferguson; Monika Janda; Patsy Yates; Amanda B Spurdle; Sandra C Hayes
Journal:  Lymphat Res Biol       Date:  2012-03-09       Impact factor: 2.589

Review 2.  Biological properties of VEGF/VPF receptors.

Authors:  B I Terman; M Dougher-Vermazen
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

3.  Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.

Authors:  E Hatva; T Böhling; J Jääskeläinen; M G Persico; M Haltia; K Alitalo
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

4.  The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.

Authors:  T Davis-Smyth; H Chen; J Park; L G Presta; N Ferrara
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

5.  Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains.

Authors:  D Rousset; F Agnès; P Lachaume; C André; F Galibert
Journal:  J Mol Evol       Date:  1995-10       Impact factor: 2.395

6.  Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.

Authors:  G Smith; D McLeod; D Foreman; M Boulton
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

7.  Anti-angiogenesis approach to genitourinary cancer treatment.

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Update Cancer Ther       Date:  2009

8.  Multiple receptor tyrosine kinases are expressed in adult rat retinal ganglion cells as revealed by single-cell degenerate primer polymerase chain reaction.

Authors:  Niclas Lindqvist; Ulrika Lönngren; Marta Agudo; Ulla Näpänkangas; Manuel Vidal-Sanz; Finn Hallböök
Journal:  Ups J Med Sci       Date:  2010-02       Impact factor: 2.384

9.  Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors.

Authors:  E Hatva; A Kaipainen; P Mentula; J Jääskeläinen; A Paetau; M Haltia; K Alitalo
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 10.  Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Authors:  W Kolch; G Martiny-Baron; A Kieser; D Marmé
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.